Literature DB >> 2041511

Improving surveillance of infectious diseases in New South Wales.

R L Rushworth1, S M Bell, G L Rubin, R M Hunter, M J Ferson.   

Abstract

OBJECTIVE: To determine the feasibility of laboratory reporting of infectious diseases and to compare the value of this system with the existing medical practitioner notification system.
DESIGN: A sample of notifications was selected from medical practitioner notifications and was compared for both completeness and timeliness of notification with a sample of notifications obtained through the Laboratory Infectious Diseases Surveillance Project.
SETTING: The New South Wales Health Department and the Public Health Unit of the Eastern Sydney Area Health Service. PARTICIPANTS: Medical practitioners forwarding notifications of infectious diseases to the New South Wales Health Department and laboratories participating in the Laboratory Infectious Diseases Surveillance Project. MAIN OUTCOME MEASURES: We counted the number of infectious diseases reported by medical practitioners and participating laboratories and estimated the proportion of these diseases which were common to both sources of data. We also estimated the time taken between the diagnosis of a notifiable infectious disease and the receipt of the notification by the Medical Officer of Health.
RESULTS: There was substantial underreporting of notifiable infectious diseases by medical practitioners. During the study there were 461 cases of a notifiable disease reported by either medical practitioners or by participating laboratories. Of these cases, 75% were reported only by laboratory staff, 20.2% were reported by medical practitioners alone and 4.8% of cases were reported by both laboratory staff and medical practitioners. The Medical Officer of Health received the reports from the participating laboratories within a significantly shorter time than the notifications from medical practitioners.
CONCLUSION: The use of infectious disease notifications by laboratories can substantially improve the surveillance of infectious diseases.

Entities:  

Mesh:

Year:  1991        PMID: 2041511     DOI: 10.5694/j.1326-5377.1991.tb121376.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.

Authors:  Patricia Campbell; Peter McIntyre; Helen Quinn; Linda Hueston; Gwendolyn L Gilbert; Jodie McVernon
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

2.  A secure protocol for protecting the identity of providers when disclosing data for disease surveillance.

Authors:  Khaled El Emam; Jun Hu; Jay Mercer; Liam Peyton; Murat Kantarcioglu; Bradley Malin; David Buckeridge; Saeed Samet; Craig Earle
Journal:  J Am Med Inform Assoc       Date:  2011-05-01       Impact factor: 4.497

3.  Physician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak.

Authors:  Khaled El Emam; Jay Mercer; Katherine Moreau; Inese Grava-Gubins; David Buckeridge; Elizabeth Jonker
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

4.  Analysis of timeliness of infectious disease reporting in the Netherlands.

Authors:  Elisabeth Reijn; Corien M Swaan; Mirjam E E Kretzschmar; Jim E van Steenbergen
Journal:  BMC Public Health       Date:  2011-05-30       Impact factor: 3.295

5.  Notifiable disease surveillance and practicing physicians.

Authors:  Gérard Krause; Gwendolin Ropers; Klaus Stark
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

6.  Timeliness of national notifiable diseases surveillance system in Korea: a cross-sectional study.

Authors:  Hyo-Soon Yoo; Ok Park; Hye-Kyung Park; Eun-Gyu Lee; Eun-Kyeong Jeong; Jong-Koo Lee; Sung-Il Cho
Journal:  BMC Public Health       Date:  2009-03-31       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.